Antiviral activity of polyporoid mushrooms (higher Basidiomycetes) from Altai Mountains (Russia)

International Journal of Medicinal Mushrooms

Volumn 14, Issue 1, 2012, Pages 37-45

  Teplyakova, Tamara V ^a   Psurtseva, Nadezhda V ^b   Kosogova, Tatiana A ^a   Mazurkova, Natalia A ^a   Khanin, Viacheslav A ^b   Vlasenko, Viacheslav A ^c  

^a STATE RESEARCH CENTER OF VIROLOGY AND BIOTECHNOLOGY VECTOR   (Russian Federation)

^b KOMAROV BOTANICAL INSTITUTE   (Russian Federation)

^c RUSSIAN ACADEMY OF SCIENCES   (Russian Federation)

Author keywords

Altai mountais; Antiviral activity; Bioactive compounds; Higher basidiomycetes; Medicinal mushrooms; Polypores

Indexed keywords

FUNGAL EXTRACT; POLYPOROID MUSHROOM EXTRACT; UNCLASSIFIED DRUG; ANTIVIRUS AGENT;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; BASIDIOMYCETES; CONTROLLED STUDY; INFLUENZA A; NONHUMAN; POLYPOROID MUSHROOM; RUSSIAN FEDERATION; VIRUS STRAIN; ANIMAL; CELL LINE; CHEMISTRY; DOG; DRUG EFFECT; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1;

AVES; BASIDIOMYCOTA; DAEDALEOPSIS CONFRAGOSA; DATRONIA MOLLIS; FOMITOPSIS OFFICINALIS; FUNGI; ISCHNODERMA BENZOINUM; LENZITES BETULINA; ORTHOMYXOVIRIDAE; TRAMETES GIBBOSA;

ANIMALS; ANTIVIRAL AGENTS; BASIDIOMYCOTA; CELL LINE; DOGS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; RUSSIA;

EID: 84859486315     PISSN: 15219437     EISSN: 19404344     Source Type: Journal    
DOI: 10.1615/IntJMedMushr.v14.i1.40     Document Type: Article

References (51)

1. Jong SR, Donovick R. Antitumor and antiviral substances from fungi. Adv Appl Microbiol. 1989;34:183-262.
2. Zjawiony JK. Biologically active compounds from Aphyllophorales (Polypore) fungi. J Nat Prod. 2004;67:300-10.
3. Lindequist U, Niedermeyer THJ, Julich W-D. The pharmacological potential of mushrooms. Evid Based Complement Altern Med. 2005;2:263-65.
4. Anke T, Thines E. Fungal metabolites as lead structures for agriculture. In: Robson GD, Van West P, Gadd GM (Eds.). Exploitation of fungi. Cambridge University Press; 2007. p. 45-58.
5. Wasser SP. Medicinal mushroom science: history, current status, future trends, and unsolved problems. Int J Med Mushr. 2010; 12:1-16.
6. Chamberlain M. Ethnomycological experiences in South West China. Mycologist. 1996;10:13-6.
7. Denisova NP. Traditions of using medicinal mushrooms in different nations. Int J Med Mushr. 2001;3:409-15.
8. Guzman G. Hallucinogenic, medicinal, and edible mushrooms in Mexico and Guatemala: traditions, myths, and knowledge. Int J Med Mushr. 2001;3:399-408.
9. Lampman AM. Ethnomycology: medicinal and edible mushrooms of the Tzeltal Maya of Chiapas, México. Int J Med Mushr. 2007;9:1-5.
10. Chang ST. Global impact of edible and medicinal mushrooms on human welfare in the 21st century: nongreen revolution. Int J Med Mushr. 1999;1:1-8.
11. Wasser S.P. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol. 2002;60:258-74.
12. Kirk PM, Cannon PF, Minter DW, Stalpers JA. Dictionary of the fungi. 10th ed. Wallingford: CABI Bioscience; 2008.
13. Hadeler H. Medicinal mushrooms you can grow. Sechelt, BC: Carriaga Press; 1995.
14. Hobbs C. Medicinal mushrooms: an exploration of tradition, healing and culture. Summertown, TN: Botanica Press; 1995.
15. Belova N. Perspectives of use of biologically active substances from higher Basidiomycetes in Russia. Mikol Fitopatol. 2004;38:1-7.
16. Stamets P. Mycelium running: how mushrooms can help save the world. Berkeley, CA: Ten Speed Press; 2005.
17. Suay I, Arenal F, Asensio FJ, Basilio A, Cabello MA, Díez MT, García JB, del Val AG, Gorrochategui J, Hernández P, Pelaez F, Vincente MF. Screening of Basidiomycetes for antimicrobial activities. Antonie van Leeuwenhoek. 2000;78:129-40.
18. Vahidi H, Kobarfard F, Namjoyan F. Effect of cultivation conditions on growth and antifungal activity of Mycena leptocephala. African J Biotechnol. 2004;3:606-9.
19. Aqueveque P, Becerra J, Palfner G, Silva M, Alarcón J, Anke T, Sterner O. Antimicrobial activity of metabolites from mycelial cultures of Chilean Basidiomycetes. J Chil Chem Soc. 2006;51:1057-60.
20. Aqueveque P, Anke T, Saéz K, Silva M, Becerra J. Antimicrobial activity of submerged cultures of Chilean Basidiomycetes. Planta Med. 2010;76:1787-91.
21. Tsvetkova I, Naydenski H, Assya Petrova A, Kostadinova E, Gyosheva M, Georgieva P, Bankova V, Popov S. Antibacterial activity of some Bulgarian higher Basidiomycetes mushrooms. Int J Med Mushr. 2006;8:63-6.
22. Carvalho MP, van der Sand ST, Rosa EAR, Germani JC, Ishikawa NK. Investigation of the antibacterial activity of Basidiomycetes Lentinula boryana and Lentinula edodes. Biociências. 2007;15:173-79.
23. Takehara M, Kuida K, Mori K. Antiviral activity of virus-like particles from Lentinus edodes (Shiitake). Brief report. Archiv Virol. 1979;59:269-74.
24. Autrou I, Amoros M, Boustie J, Girre L. In vitro study of antiviral activity of Macromycetes. Plantes Medicinales et Phytotherapie. 1994;26:347-55.
25. Amoros M, Boustie J, Py M-L, Hervé V, Robin V, Girre L. Antiviral activity of Homobasidiomycetes: evaluation of 121 Basidiomycetes extracts on four viruses. Pharm Biol. 1997;35:255-60.
26. Eo S-K, Kim Y-S Lee C-K, Han S-S. Antiviral activities of various water and methanol soluble substances isolated from Ganoderma lucidum. J Ethnopharm. 1999;68:129-36.
27. Awadh Ali NA, Mothanaa RAA, Lesnauc A, Pilgrima H, Lindequist U. Antiviral activity of Inonotus hispidus. Fitoterapia. 2003;74:483-85.
28. Bruggemann R, Orlandi JM, Benati FJ, Faccin LC, Mantovani MS, Nozawa C, Linhares REC. Antiviral activity of Agaricus blazei Murrill ss. Heinem. extract against human and bovine herpes viruses in cell culture. Braz J Microbiol. 2006;37:561-65.
29. Pirano F. Emerging antiviral drugs from medicinal mushrooms. Int J Med Mushr. 2006; 8:101-14.
30. Kamps BS, Reyes-Teran G. INFL Rep. 2006;17-47.
31. Reed LJ. Muench H. A simple method of estimating fifty percent endpoints. Am J Hygiene. 1938;27:493-97.
32. Sachs L. Statistical estimation. M. Moscow: Statistika; 1976.
33. Ohtsuka S, Ueno S, Yoshikumi C, Hirose F, Ohmura Y, Wada T, Fujii T, Takahashi E. Polysaccharides having an anticarcinogenic effect and a method of producing them from species of Basidiomycetes. UK Patent No. 1331513; 1973.
34. Kim EM, Jung HR, Min TJ. Purification, structure determination and biological activities of 20(29)-lupen-3-one from Daedaleopsis tricolor (Bull. ex Fr.) Bond. et Sing. Bull Kor Chem Soc. 2001;22:59-62.
35. Melzig MF, Pieper S, Siems WE, Heder G, Böttger A, Liberra K. Screening of selected basidiomycetes for inhibitory activity on neutral endopeptidase (NEP) and angiotensin-converting enzyme (ACE). Pharmazie. 1996;51:501-3.
36. Dembitsky VM, Shubina EE, Kashin AG. Phospholipid and fatty acid composition of some Basidiomycetes. Phytochem. 1992;31:845-49.
37. Dembitsky VM, Rezanka T, Shubina EE. Unusual hydroxy fatty acids from some higher fungi. Phytochem. 1993;34:1057-59.
38. Pemberton RT. Agglutinins (lectins) from some British higher fungi. Mycol Res. 1994;98:277-90.
39. Rösecke J, König WA. Constituents of the fungi Daedalea quercina and Daedaleopsis confragosa var. tricolor. Phytochem. 2000;54:757-62.
40. Yaoita Y, Ebina K, Kakuda R, Machida K, Kikuchi M. Sterol constituents from Daedaleopsis tricolor. Nat Med. 2002;56:117-9.
41. Yamac M, Zeytinoglu M, Kanbak G, Bayramoglu G, Senturk H. Hypoglycemic effect of crude exopolysaccharides produced by Cerrena unicolor, Coprinus comatus, and Lenzites betulina isolates in streptozotocin-induced diabetic rats. Pharm Biol. 2009;47:168-74.
42. Kawagishi H, Mizuno T. Purification and properties of a β-galactosyl-specific lectin from the fruiting bodies of Ischnoderma resinosus. FEBS Lett. 1988;227:99-102.
43. Kawagishi H, Mori H. Chemical modification and NMR studies on a mushroom lectin Ischnoderma resinosum agglutinin IRA. Biochem Biophys Acta. 1991;1076:179-86.
44. Stamets P. Antiviral activity from medicinal mushrooms. Shelton, WA, US Patent No. 20050276815; 2005.
45. Tochikura TS, Nakashima H, Hirose K, Yamamoto N. A biological response modifier, PSK, inhibits human immunodeficiency virus infection in vitro. Biochem Biophys Res Comm. 1987;148:726-33.
46. Colins RA, Ng TB. Polysaccaropeptide fron Trametes versicolor has potential for use against human immunodeficiency virus type 1 infection. Life Sci. 1997;60:383-87.
47. Mlinaric A, Kac J, Pohleven F. Screening of selected wood-damaging fungi for the HIV-1 reverse transcriptase inhibitors. Act Pharm. 2005;55:69-79.
48. Tomasi S, Lohezic-Le Devehat F, Sauleau P, Bezivin C, Boustie J. Cytotoxic activity of methanol extracts from Basidiomycete mushrooms on murine cancer cell lines. Pharmazie. 2004;59:290-93.
49. Stamets P. MycoMedicinals. An informational treatise on mushrooms. Olympia, WA: MycoMedia Productions; 2002.
50. Polisshuk OM, Kovalenko OG. Biological activity glikopolimers of Basidiomycetes. Biopolymers and Cells. 2009;25(3):1181-93.
51. Collins RA, Ng TB. Polysaccaropeptide from Trametes versicolor has potential for use against human immunodeficiency virus type 1 infection. Life Sci. 1997;60(25):383-87.